These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3043428)

  • 1. PAF-acether and eosinophils.
    Hénocq E
    Prog Biochem Pharmacol; 1988; 22():141-8. PubMed ID: 3043428
    [No Abstract]   [Full Text] [Related]  

  • 2. Properties of PAF-acether appropriate to a mediator of the inflammatory aspects of asthma.
    Page CP; Archer CB; Guerreiro D; Morley J
    Int J Tissue React; 1985; 7(5):351-4. PubMed ID: 4055261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleural eosinophil infiltration induced by PAF-acether is not a desensitizable phenomenon.
    Silva PM; Martins MA; Castro-Faria-Neto HC; Bozza PT; Cruz HN; Dias MT; Cordeiro RS; Vargaftig BB
    Braz J Med Biol Res; 1990; 23(10):1009-13. PubMed ID: 2101050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
    Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
    J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for platelet activating factor and platelets in the induction of bronchial hyperreactivity.
    Page CP
    Int J Tissue React; 1987; 9(1):27-32. PubMed ID: 3298115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils.
    Kroegel C; Yukawa T; Dent G; Chanez P; Chung KF; Barnes PJ
    Immunology; 1988 Jul; 64(3):559-61. PubMed ID: 3410498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAF-acether: a putative mediator of asthma and inflammation.
    Page CP; Paul W; Dewar A; Wood L; Basran GS; Morley J
    Agents Actions Suppl; 1983; 13():177-83. PubMed ID: 6575595
    [No Abstract]   [Full Text] [Related]  

  • 8. PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin.
    Wal F; Joseph D; Touqui L; Vargaftig BB
    Thromb Haemost; 1985 Feb; 53(1):99-104. PubMed ID: 3992525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paf-acether (platelet-activating factor).
    Benveniste J
    Bull Eur Physiopathol Respir; 1986; 22 Suppl 7():91-4. PubMed ID: 3955269
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
    Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
    J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro.
    Berdel WE; Korth R; Reichert A; Houlihan WJ; Bicker U; Nomura H; Vogler WR; Benveniste J; Rastetter J
    Anticancer Res; 1987; 7(6):1181-7. PubMed ID: 3442414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory characteristics of PAF-acether in the skin of experimental animals and man.
    Archer CB; Page CP; Paul W; Morley J; MacDonald DM
    Int J Tissue React; 1985; 7(5):363-5. PubMed ID: 3863807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct action of platelet activating factor (PAF) induces eosinophil accumulation and enhances expression of PAF receptors in conjunctivitis.
    Zinchuk O; Fukushima A; Zinchuk V; Fukata K; Ueno H
    Mol Vis; 2005 Feb; 11():114-23. PubMed ID: 15735601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics.
    Kroegel C; Matthys H
    Immunology; 1993 Feb; 78(2):279-85. PubMed ID: 8473016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig.
    Dewar A; Archer CB; Paul W; Page CP; MacDonald DM; Morley J
    J Pathol; 1984 Sep; 144(1):25-34. PubMed ID: 6481526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pivotal role of 5-lipoxygenase in the activation of human eosinophils: platelet-activating factor and interleukin-5 induce CD69 on eosinophils through the 5-lipoxygenase pathway.
    Urasaki T; Takasaki J; Nagasawa T; Ninomiya H
    J Leukoc Biol; 2001 Jan; 69(1):105-12. PubMed ID: 11200053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
    Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
    J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of PAF-acether (platelet activating factor) in cardio-vascular pathology].
    Gateau O
    Arch Mal Coeur Vaiss; 1987 May; 80 Spec No():51-2. PubMed ID: 3117010
    [No Abstract]   [Full Text] [Related]  

  • 19. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor.
    Horie S; Kita H
    J Immunol; 1994 Jun; 152(11):5457-67. PubMed ID: 7514638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of platelet-activating factor (PAF) on eosinophil adhesion to plasma-coated glass using eosinophilic cell lines (EoL-1, EoL-3)].
    Kakazu T; Chihara J; Saito A; Hayashi N; Higashimoto I; Kurachi D; Yamamoto T; Nakajima S
    Arerugi; 1994 Apr; 43(4):590-4. PubMed ID: 8031255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.